The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Saprykina L.V.

Kafedra akusherstva i ginekologii Moskovskogo fakul'teta Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Dobrokhotova Iu.É.

Kafedra akusherstva i ginekologii Moskovskogo fakul'teta Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Saprykina O.A.

FGBOU VPO "Rossiĭskiĭ universitet druzhby narodov", Moskva

Peshkin V.I.

FGBOU VPO "Rossiĭskiĭ universitet druzhby narodov", Moskva

The cell and humoral immunity in premenopausal women with endometrial hyperplasia

Authors:

Saprykina L.V., Dobrokhotova Iu.É., Saprykina O.A., Peshkin V.I.

More about the authors

Read: 1078 times


To cite this article:

Saprykina LV, Dobrokhotova IuÉ, Saprykina OA, Peshkin VI. The cell and humoral immunity in premenopausal women with endometrial hyperplasia. Russian Journal of Human Reproduction. 2013;(2):95‑98. (In Russ.)

Recommended articles:
Use of gona­dotropic releasing hormone agonists in hype­rplastic syndrome in gyne­cology. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):51-58
The possibilities of realizing reproductive function in women with endo­metrial hype­rplasia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):98-105
Endo­metrial vascularisation in hype­rplasia without atypia. Russian Journal of Archive of Pathology. 2025;(6):28-33

References:

  1. Haabeth O.A., Bogen B., Corthay A. A model for cancer-suppressive inflammation. Oncoimmunology 2012; 1: 7: 1146-1155.
  2. Oleinika K., Nibbs R.J., Graham G.J., Fraser A.R. Suppression, subversion and escape: the role of regulatory T cells in cancer progression. Clin Exp Immunol 2013; 171: 1: 36-45.
  3. Sckisel G.D., Murphy W.J. Specificity may be overrated in cancer immunotherapy: Getting to know the nonspecific side of memory T-Cells. Oncoimmunology 2012; 1: 7: 1208-1210.
  4. Peggs K.S., Quezada S.A. PD-1 blockade: promoting endogenous anti-tumor immunity. Exp Rev Anticancer Ther 2012; 12: 10: 1279-1282.
  5. Brown M.D., van der Most R., Vivian J.B. et al.  Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8(+) T-cell immunity. Oncoimmunology 2012; 1: 7: 1084-1094.
  6. Lowdell M.W. Natural Killer T-cells - balancing the regulation of tumor immunity. Br J Cancer 2012; 107: 10: 1795-1796.
  7. Dranik G.N. Klinicheskaya immunologiya i allergologiya: posobie dlya studentov, vrachei-internov, immunologov, allergologov, vrachei lechebnogo profilya vsekh spetsial'nostei. Kiev: Poligraf plyus 2006; 482.
  8. Lysenko O.V., Zan'ko S.N. Tsitokiny i sFas-ligand pri giperplasticheskikh protsessakh i polipakh endometriya. Probl reprod 2010; 5: 31-35.
  9. Lukach A.A. Giperplasticheskie protsessy genitalii, assotsiirovannye s infektsionnymi patogenami (patogenez, klinika, diagnostika): Avtoref. dis. … d-ra med. nauk. M 2010; 43.
  10. Gameiro C., Romao F. Changes in the immune system during menopause and aging. Front Biosci (Elite Ed) 2010; 1: 2: 1299-1303.
  11. Muñoz-Cruz S., Togno-Pierce C., Morales-Montor J. Non-reproductive effects of sex steroids: their immunoregulatory role. Curr Top Med Chem 2011; 11: 13: 1714-1727.
  12. Michalek R.D., Gerriets V.A., Nichols A.G. et al.  Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation. Proc Natl Acad Sci USA 2011; 108: 45: 18348-18353.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.